Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/11/2025

Treatment of Pseudomonas Aeruginosa in Sacral Wounds

Initial Assessment and Surgical Management

  • The Infectious Diseases Society of America recommends urgent surgical consultation for sharp debridement when systemic signs of infection are present, such as fever, hypotension, and elevated white blood cell count, in patients with sacral wounds 1
  • Deep intraoperative tissue or abscess fluid should be obtained for culture during debridement to guide definitive antibiotic therapy in patients with sacral wounds 1
  • Debridement removes necrotic tissue and biofilm, which is essential since sacral wounds harbor polymicrobial infections with anaerobes thriving in the extracellular polymeric substance, according to the Clinical Infectious Diseases guidelines 1

Empiric Antibiotic Selection

  • The American Diabetes Association recommends that empiric antipseudomonal coverage is not routinely required for sacral pressure injuries unless specific risk factors are present, such as high local prevalence of Pseudomonas infections, warm climate, frequent exposure of the wound to water, recent antibiotic therapy, or healthcare-associated infection 3
  • The Infectious Diseases Society of America suggests that when antipseudomonal coverage is warranted, appropriate empiric regimens include piperacillin-tazobactam as first-line broad-spectrum coverage, although this information is also available from Praxis Medical Insights, the IDSA recommendation is preferred 1

Definitive Antibiotic Therapy

  • The Diabetes/Metabolism Research and Reviews guidelines recommend that once culture results are available, narrow the antibiotic spectrum to target only isolated pathogens in patients with sacral wounds 3
  • The Clinical Infectious Diseases guidelines suggest that if the infection is improving on empiric therapy, continuation may be appropriate even if some organisms show in vitro resistance, in patients with sacral wounds 3

Duration of Antibiotic Therapy

  • The Clinical Infectious Diseases guidelines recommend that the duration of antibiotic therapy depends on the clinical scenario, with skin and soft tissue infection without abscess typically requiring 5 days of treatment, and with abscess requiring 5-10 days following drainage, in patients with sacral wounds 1
  • The Infectious Diseases Society of America recommends that stage IV pressure injury without soft tissue infection and pelvic osteomyelitis without soft tissue infection and no surgical plans do not require systemic antibiotics, according to the Clinical Infectious Diseases guidelines 1

Critical Pitfalls to Avoid

  • The Clinical Infectious Diseases guidelines recommend that antipseudomonal antibiotics should not be prescribed empirically for sacral wounds without risk factors, as Pseudomonas is not among the most common pathogens in these infections, according to the Infectious Diseases Society of America 1
  • The Praxis Medical Insights guidelines suggest that surgical debridement should not be delayed when systemic signs are present, as antibiotics alone will fail without source control, although this information is also available from other sources, the Praxis Medical Insights guideline is not preferred 2
  • The Diabetes/Metabolism Research and Reviews guidelines recommend that broad-spectrum antibiotics should not be continued once cultures identify specific pathogens—narrow coverage to prevent resistance, in patients with sacral wounds 3

Local Epidemiology Considerations

  • The Clinical Infectious Diseases guidelines suggest that local epidemiology should be considered when selecting empiric therapy, with up to 85% of Staphylococcus aureus from pressure injuries potentially being methicillin-resistant, and 21.6% of gram-negatives potentially being multidrug-resistant, in some settings 1

Monitoring Response

  • The Praxis Medical Insights guidelines recommend that clinical response should be reassessed at 48-72 hours and obtain repeat cultures if inadequate improvement, although this information is also available from other sources, the Praxis Medical Insights guideline is not preferred 2
  • The Clinical Infectious Diseases guidelines suggest that signs of spreading infection, such as increasing erythema beyond 5 cm, fever >38.5°C, and heart rate >110 bpm, should be watched for, in patients with sacral wounds 4